PCNA and Familial prostate cancer: Pharmacological inhibition of PCNA with AOH1996 significantly suppressed tumor growth and enhanced the efficacy of androgen deprivation therapy.<h4>Conclusion</h4>We developed the SRGS that effectively predicts prostate cancer prognosis and progression.